Precisely how is digital and telehealth changing the way health care is being delivered? We catch up with LEK's digital guru Klaus Boehncke who is full of examples!
A five and a half year education (Batchelor + Masters) as a doctor for just €100,000? That is what is on offer from EDU Malta, a for-profit educational institute with statutes which commit it to working for the public good. It is working closely with Fresenius Helios and other German hospitals and is looking for hospital partners in other countries. So how does it work, what are EDU’s plans and what role could this play in dealing with the massive world shortage of doctors?
Big US managed care company Centene has stated that it is conducting a strategic review of its international arm - Circle Health in the UK and Grupo Ribera Salud in Spain and elsewhere in Europe.
Life science properties that incorporate some laboratories in one form or another could be the next property boom says Piers Scrimshaw-Wright, who has just joined Knight Frank as Life Science and Innovation partner. So has anything been sold in Europe so far?
Quironsalud, the Spanish arm of Fresenus Helios has expanded its Colombian business with the acquisition of Centro Oncológico de Antioquia and ophthalmology centre Clínica Clofán. In its nine month results Fresenius stated that Latin America were strong and "notably above expectations." We look at a booming market where Fresenius Helios spent the lion's share of its €770m on M&A deals in 2020 and 2019 alone.
Municipality-owned French care homes are in crisis. Tired, old buildings, with low tariffs and now, following Covid, far lower occupancy rates are leading many to consider the unthinkable: privatisation.
Two strategics and a private equity player are bidding for Unilabs, the Pan-European, Mid East and LaTam lab and imaging group. So who is likely to win?
At the start of this year, there was a lot of optimism around dentistry. The dental sector was seen as one of the biggest and most exciting opportunities for private operators and investors. Largely unconsolidated across Europe and beyond, many asked ‘when will we see a truly pan-European operator'? COVID derailed all expectations of the year but with a vaccine now in play, what are the prospects for consolidation and expansion? HBI 2020 gathered a panel of experts to find out more.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
